myTomorrows is a leading service provider specializing in expanded access, with over a decade of expertise managing over 50 Expanded Access Programs. With a reach extending to 12,000 patients and 2,500 healthcare professionals across 50 countries, we are dedicated to facilitating access to innovative treatments.
Our approach revolves around a platform-centric model that seamlessly integrates advanced technology with personalized physician support to streamline the EAP application process. Complemented by our proficient site management and workflows tailored to the specific requirements of our Biopharma partners, we ensure effective program management.
Our dedicated real-world data team offers an integrated approach in RWD strategy, collection, and analysis of data in non-interventional settings.
We take pride in our commitment to regulatory compliance and maintaining rigorous quality standards for each project. With a team of over 100, across the United States and Europe, equipped with experience in quality and regulatory, we are well placed to help you design expanded access strategies.
www.mytomorrows.com
